+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-infectives Market - Global Forecast 2026-2032- Product Image
Anti-infectives Market - Global Forecast 2026-2032- Product Image
New

Anti-infectives Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 191 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015081
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anti-infectives market is rapidly transforming in response to evolving clinical practices, regulatory demands, and supply chain dynamics. Senior healthcare executives face a complex landscape requiring coordinated strategies for product development, commercialization, and long-term access to critical anti-infective therapies.

Market Snapshot: Anti-Infectives Market Performance

The Anti-infectives Market grew from USD 138.37 billion in 2025 to USD 146.30 billion in 2026. It is expected to continue growing at a CAGR of 5.38%, reaching USD 199.73 billion by 2032.

Scope & Segmentation

  • Therapeutic Classes: Antibiotics (aminoglycosides, beta-lactams, fluoroquinolones, macrolides, sulfonamides, tetracyclines), Antifungals (allylamines, azoles, echinocandins, polyenes), Antivirals (neuraminidase inhibitors, nucleoside analogues, polymerase inhibitors, protease inhibitors), Antiparasitics (anthelmintics, antimalarials, antiprotozoals)
  • Indications: Bloodstream, gastrointestinal, respiratory, skin and soft tissue, and urinary tract infections; specialized respiratory segment includes bronchitis, community-acquired, and hospital-acquired pneumonia
  • Routes of Administration: Inhalation, oral, parenteral, and topical, each with unique implications for logistics and adherence strategies
  • Channels & End-users: Drug stores, hospital pharmacies, online pharmacies, retail pharmacies; hospitals, clinics, home care settings, reflecting procurement cycles and stewardship oversight
  • Regional Coverage: Americas; Europe, Middle East & Africa; Asia-Pacific, each with distinct regulatory frameworks, payer models, access pathways, and public health priorities
  • Technology & Innovation: Rapid molecular diagnostics, real-world evidence tools, expanded stewardship programs, and investment in platform technologies for new modalities

Key Takeaways for Senior Decision-Makers

  • Scientific innovation and accelerated diagnostics are at the core of leading anti-infective strategies, shaping how care providers identify and manage infections.
  • Policy environments increasingly link reimbursement to stewardship metrics and value-based procurement, impacting engagement with payers and policymakers.
  • Market access differs widely by region: while the Americas emphasize integrated stewardship and payer connectivity, Europe and the Middle East focus on centralized purchasing and access partnerships, and Asia-Pacific highlights generics competition and biosafety standards.
  • Outpatient and home-based care drive demand for flexible administration routes and targeted packaging solutions, requiring adjustment in product design and support programs.
  • Cross-sector collaborations—spanning diagnostics, public health agencies, and contract manufacturers—are critical for expanding access and achieving sustainable growth.

Tariff Impact: Navigating Cost and Supply Chain Shifts

Anticipated United States tariff changes in 2025 introduce new cost and logistical complexities for pharmaceutical supply chains worldwide. These shifts are prompting manufacturers and distributors to reconsider sourcing strategies, diversify active pharmaceutical ingredient procurement, and evaluate nearshoring options. Adjustments in contractual terms, supplier flexibility, and documentation requirements are now essential to ensure uninterrupted flow, especially for sterile and temperature-sensitive anti-infective products.

Methodology & Data Sources

This report leverages expert interviews with clinical, procurement, and supply-chain executives, combined with evidence synthesis from peer-reviewed literature, regulatory updates, surveillance data, and sector white papers. Data triangulation and comparative regional analysis underpin the findings, ensuring both relevance and actionable insights.

Why This Report Matters

  • Enables informed strategic planning in a dynamic anti-infectives market shaped by evolving clinical demands, payer requirements, and regulatory trends.
  • Provides a foundational understanding of segment relevance, regional drivers, and the role of diagnostic and supply chain innovation for ongoing portfolio development.
  • Equips senior leaders with practical recommendations to enhance investment prioritization, supply resilience, and sustainable market access strategies.

Conclusion

The anti-infectives sector demands integrated strategies rooted in clinical, commercial, and operational alignment. Organizations that connect diagnostic advances, resilient manufacturing, and adaptive commercialization will be best positioned to secure competitive advantage and optimize patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Anti-infectives Market, by Product Type
8.1. Antibiotics
8.1.1. Aminoglycosides
8.1.2. Beta Lactams
8.1.3. Fluoroquinolones
8.1.4. Macrolides
8.1.5. Sulfonamides
8.1.6. Tetracyclines
8.2. Antifungals
8.2.1. Allylamines
8.2.2. Azoles
8.2.3. Echinocandins
8.2.4. Polyenes
8.3. Antiparasitics
8.3.1. Anthelmintics
8.3.2. Antimalarials
8.3.3. Antiprotozoals
8.4. Antivirals
8.4.1. Neuraminidase Inhibitors
8.4.2. Nucleoside Analogues
8.4.3. Polymerase Inhibitors
8.4.4. Protease Inhibitors
9. Anti-infectives Market, by Indication
9.1. Bloodstream Infections
9.2. Gastrointestinal Infections
9.3. Respiratory Infections
9.3.1. Bronchitis
9.3.2. Community Acquired Pneumonia
9.3.3. Hospital Acquired Pneumonia
9.4. Skin And Soft Tissue Infections
9.5. Urinary Tract Infections
10. Anti-infectives Market, by Route Of Administration
10.1. Inhalation
10.2. Oral
10.3. Parenteral
10.4. Topical
11. Anti-infectives Market, by Distribution Channel
11.1. Online
11.2. Offline
12. Anti-infectives Market, by End User
12.1. Clinics
12.2. Home Care Settings
12.3. Hospitals
13. Anti-infectives Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Anti-infectives Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Anti-infectives Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Anti-infectives Market
17. China Anti-infectives Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. AbbVie Inc
18.7. Astellas Pharma Inc
18.8. AstraZeneca plc
18.9. Aurobindo Pharma Limited
18.10. Bayer AG
18.11. Biocon Limited
18.12. Boehringer Ingelheim GmbH
18.13. Bristol Myers Squibb
18.14. Cipla Limited
18.15. Dr. Reddy's Laboratories Ltd
18.16. Eli Lilly and Company
18.17. F. Hoffmann-La Roche Ltd
18.18. Gilead Sciences Inc
18.19. GlaxoSmithKline plc (GSK)
18.20. Glenmark Pharmaceuticals Limited
18.21. Johnson & Johnson
18.22. Lupin Limited
18.23. Merck & Co Inc
18.24. Novartis AG
18.25. Otsuka Pharmaceutical Co Ltd
18.26. Pfizer Inc
18.27. Sanofi
18.28. Shionogi & Co Ltd
18.29. Sun Pharmaceutical Industries Limited
18.30. Teva Pharmaceutical Industries Limited
18.31. Viatris Inc
18.32. Wockhardt Limited
18.33. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY FLUOROQUINOLONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY FLUOROQUINOLONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ALLYLAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ALLYLAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AZOLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AZOLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AZOLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ECHINOCANDINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ECHINOCANDINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYENES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYENES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYENES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTHELMINTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTHELMINTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIMALARIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIMALARIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIMALARIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPROTOZOALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPROTOZOALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NUCLEOSIDE ANALOGUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NUCLEOSIDE ANALOGUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NUCLEOSIDE ANALOGUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYMERASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYMERASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYMERASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PROTEASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PROTEASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY URINARY TRACT INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY URINARY TRACT INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. EUROPE ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. EUROPE ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 175. EUROPE ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 176. EUROPE ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 178. EUROPE ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 179. EUROPE ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. EUROPE ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. AFRICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. AFRICA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 196. AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 197. AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 199. AFRICA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 200. AFRICA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 201. AFRICA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. AFRICA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. AFRICA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 219. ASEAN ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 220. ASEAN ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 221. ASEAN ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 222. ASEAN ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 223. ASEAN ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 224. ASEAN ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. ASEAN ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 226. ASEAN ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. GCC ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. GCC ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 229. GCC ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 230. GCC ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 231. GCC ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 232. GCC ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 233. GCC ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 234. GCC ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 235. GCC ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. GCC ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. GCC ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. BRICS ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. BRICS ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. BRICS ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 252. BRICS ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 253. BRICS ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 254. BRICS ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 255. BRICS ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 256. BRICS ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 257. BRICS ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 258. BRICS ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 259. BRICS ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. G7 ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. G7 ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 262. G7 ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 263. G7 ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 264. G7 ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 265. G7 ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 266. G7 ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 267. G7 ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 268. G7 ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 269. G7 ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. G7 ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. NATO ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 272. NATO ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 273. NATO ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 274. NATO ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 275. NATO ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 276. NATO ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 277. NATO ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 278. NATO ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 279. NATO ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 280. NATO ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 281. NATO ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 294. CHINA ANTI-INFECTIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 295. CHINA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 296. CHINA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 297. CHINA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2032 (USD MILLION)
TABLE 298. CHINA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2032 (USD MILLION)
TABLE 299. CHINA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2032 (USD MILLION)
TABLE 300. CHINA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 301. CHINA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2032 (USD MILLION)
TABLE 302. CHINA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 303. CHINA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 304. CHINA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Anti-infectives market report include:
  • Abbott Laboratories
  • AbbVie Inc
  • Astellas Pharma Inc
  • AstraZeneca plc
  • Aurobindo Pharma Limited
  • Bayer AG
  • Biocon Limited
  • Boehringer Ingelheim GmbH
  • Bristol Myers Squibb
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences Inc
  • GlaxoSmithKline plc (GSK)
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co Inc
  • Novartis AG
  • Otsuka Pharmaceutical Co Ltd
  • Pfizer Inc
  • Sanofi
  • Shionogi & Co Ltd
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc
  • Wockhardt Limited
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages191
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 146.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 199.73 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Pets Anti-infective Drugs Market - Global Forecast 2026-2032 - Product Image

Pets Anti-infective Drugs Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Pneumonia Therapeutics Market - Global Forecast 2026-2032 - Product Image

Pneumonia Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Image

Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • 136 Pages
  • Global
From
Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Anti-Infective Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Anti-Infectives - Global Strategic Business Report - Product Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From

About the Infection Drug Market

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.